Review



mock controls wildtype mefs  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 95

    Structured Review

    Cell Signaling Technology Inc mock controls wildtype mefs
    ( A ) Proliferation of B6-STIL control, CMV-STIL +/- , CMV-STIL +/+ , CMV-p53-R172H +/- and CMV-STIL +/- /p53-R172H +/- <t>MEFs.</t> Cells were enumerated every 24 h for a total of 5 days. Data are means ± SEM from three independent experiments. ( B ) Immunoblotting showing p S18 -p53 and p53 protein expression levels in protein extracts from p2-6 CMV-STIL +/- and B6-STIL control MEFs. β-actin served as a loading <t>control;</t> <t>DMSO-</t> and etoposide-treated NIH3T3 cell lysate extracts as controls for p53 increase/phosphorylation after DNA damage. The right panel shows the changes in p S18 -p53 and p53 expression compared to passage 2 (p2) of B6-STIL control MEFs. ( C ) Representative images of B6-STIL control, CMV-STIL +/- and CMV-STIL +/+ MEFs, stained for β-galactosidase-cleaved x-Gal (lower panel). In the upper panel differential contrast interference (DIC) images of the cells are shown. Scale bar, 1 μm. ( D ) Percentage of β-galactosidase-positive, senescent B6-STIL control, CMV-STIL +/- , CMV-STIL +/+ , CMV-p53-R172H +/- and CMV-STIL +/- /p53-R172H +/- MEFs. Data are means ± Clopper-Pearson 95%-CI. Comparisons were made using the two-sided Fisher’s exact test. For space reasons, only statistically significant differences are displayed. * p <0.05, ** p <0.01, *** p <0.001. ( E ) Immunoblotting showing p16 INK4A protein expression levels in protein extracts from p2-6 CMV-STIL +/- and B6-STIL control MEFs. β-actin served as a loading control. The right panel shows the changes in p16 INK4A expression compared to passage 2 (p2) of B6-STIL control MEFs. ( F ) RNA sequencing showing p16 INK4A mRNA levels in CMV-STIL +/- and CMV-STIL +/+ relative to B6-STIL control MEFs. ( G , H) Percentage of ( G ) Apo-15-positive and ( H ) sub-G 1 phase, apoptotic B6-STIL control, CMV-STIL +/- , CMV-STIL +/+ , CMV-p53-R172H +/- and CMV-STIL +/- /p53-R172H +/- MEFs. Data are means ± SEM from three independent experiments. The differences between groups were tested using the one-way ANOVA with post-hoc Tukey test for multiple comparison. No statistical significance was found. For space reasons, only statistically significant differences are displayed. ( I ) Genotyping of p3-5 CMV-STIL +/- and CMV-STIL +/+ MEFs. All passages harbor the STIL transgene. ( J ) RNA sequencing showing STIL mRNA levels in p3-5 B6-STIL control, CMV-STIL +/- and CMV-STIL +/+ MEFs. ( K ) Immunoblotting showing STIL protein expression levels in p1-5 of B6-STIL control and CMV-STIL +/- MEFs. The STIL band at 170 kDa is marked with an asterisk. β-actin served as a loading control. The lower panel shows the changes in STIL expression compared to p1 of CMV-STIL +/- MEFs. ( L ) Percentage of p3 and p6 B6-STIL control, CMV-STIL +/- , CMV-STIL +/+ , CMV-p53-R172H +/- and CMV-STIL +/- /p53-R172H +/- MEFs with supernumerary centrioles. Comparisons were made using the two-sided Fisher’s exact test. Note : for reasons of space, only statistically significant differences were marked. * p <0.05, ** p <0.01, *** p <0.001.
    Mock Controls Wildtype Mefs, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 85 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mock controls wildtype mefs/product/Cell Signaling Technology Inc
    Average 95 stars, based on 85 article reviews
    mock controls wildtype mefs - by Bioz Stars, 2026-02
    95/100 stars

    Images

    1) Product Images from "STIL overexpression shortens lifespan and reduces tumor formation in mice"

    Article Title: STIL overexpression shortens lifespan and reduces tumor formation in mice

    Journal: PLOS Genetics

    doi: 10.1371/journal.pgen.1011460

    ( A ) Proliferation of B6-STIL control, CMV-STIL +/- , CMV-STIL +/+ , CMV-p53-R172H +/- and CMV-STIL +/- /p53-R172H +/- MEFs. Cells were enumerated every 24 h for a total of 5 days. Data are means ± SEM from three independent experiments. ( B ) Immunoblotting showing p S18 -p53 and p53 protein expression levels in protein extracts from p2-6 CMV-STIL +/- and B6-STIL control MEFs. β-actin served as a loading control; DMSO- and etoposide-treated NIH3T3 cell lysate extracts as controls for p53 increase/phosphorylation after DNA damage. The right panel shows the changes in p S18 -p53 and p53 expression compared to passage 2 (p2) of B6-STIL control MEFs. ( C ) Representative images of B6-STIL control, CMV-STIL +/- and CMV-STIL +/+ MEFs, stained for β-galactosidase-cleaved x-Gal (lower panel). In the upper panel differential contrast interference (DIC) images of the cells are shown. Scale bar, 1 μm. ( D ) Percentage of β-galactosidase-positive, senescent B6-STIL control, CMV-STIL +/- , CMV-STIL +/+ , CMV-p53-R172H +/- and CMV-STIL +/- /p53-R172H +/- MEFs. Data are means ± Clopper-Pearson 95%-CI. Comparisons were made using the two-sided Fisher’s exact test. For space reasons, only statistically significant differences are displayed. * p <0.05, ** p <0.01, *** p <0.001. ( E ) Immunoblotting showing p16 INK4A protein expression levels in protein extracts from p2-6 CMV-STIL +/- and B6-STIL control MEFs. β-actin served as a loading control. The right panel shows the changes in p16 INK4A expression compared to passage 2 (p2) of B6-STIL control MEFs. ( F ) RNA sequencing showing p16 INK4A mRNA levels in CMV-STIL +/- and CMV-STIL +/+ relative to B6-STIL control MEFs. ( G , H) Percentage of ( G ) Apo-15-positive and ( H ) sub-G 1 phase, apoptotic B6-STIL control, CMV-STIL +/- , CMV-STIL +/+ , CMV-p53-R172H +/- and CMV-STIL +/- /p53-R172H +/- MEFs. Data are means ± SEM from three independent experiments. The differences between groups were tested using the one-way ANOVA with post-hoc Tukey test for multiple comparison. No statistical significance was found. For space reasons, only statistically significant differences are displayed. ( I ) Genotyping of p3-5 CMV-STIL +/- and CMV-STIL +/+ MEFs. All passages harbor the STIL transgene. ( J ) RNA sequencing showing STIL mRNA levels in p3-5 B6-STIL control, CMV-STIL +/- and CMV-STIL +/+ MEFs. ( K ) Immunoblotting showing STIL protein expression levels in p1-5 of B6-STIL control and CMV-STIL +/- MEFs. The STIL band at 170 kDa is marked with an asterisk. β-actin served as a loading control. The lower panel shows the changes in STIL expression compared to p1 of CMV-STIL +/- MEFs. ( L ) Percentage of p3 and p6 B6-STIL control, CMV-STIL +/- , CMV-STIL +/+ , CMV-p53-R172H +/- and CMV-STIL +/- /p53-R172H +/- MEFs with supernumerary centrioles. Comparisons were made using the two-sided Fisher’s exact test. Note : for reasons of space, only statistically significant differences were marked. * p <0.05, ** p <0.01, *** p <0.001.
    Figure Legend Snippet: ( A ) Proliferation of B6-STIL control, CMV-STIL +/- , CMV-STIL +/+ , CMV-p53-R172H +/- and CMV-STIL +/- /p53-R172H +/- MEFs. Cells were enumerated every 24 h for a total of 5 days. Data are means ± SEM from three independent experiments. ( B ) Immunoblotting showing p S18 -p53 and p53 protein expression levels in protein extracts from p2-6 CMV-STIL +/- and B6-STIL control MEFs. β-actin served as a loading control; DMSO- and etoposide-treated NIH3T3 cell lysate extracts as controls for p53 increase/phosphorylation after DNA damage. The right panel shows the changes in p S18 -p53 and p53 expression compared to passage 2 (p2) of B6-STIL control MEFs. ( C ) Representative images of B6-STIL control, CMV-STIL +/- and CMV-STIL +/+ MEFs, stained for β-galactosidase-cleaved x-Gal (lower panel). In the upper panel differential contrast interference (DIC) images of the cells are shown. Scale bar, 1 μm. ( D ) Percentage of β-galactosidase-positive, senescent B6-STIL control, CMV-STIL +/- , CMV-STIL +/+ , CMV-p53-R172H +/- and CMV-STIL +/- /p53-R172H +/- MEFs. Data are means ± Clopper-Pearson 95%-CI. Comparisons were made using the two-sided Fisher’s exact test. For space reasons, only statistically significant differences are displayed. * p <0.05, ** p <0.01, *** p <0.001. ( E ) Immunoblotting showing p16 INK4A protein expression levels in protein extracts from p2-6 CMV-STIL +/- and B6-STIL control MEFs. β-actin served as a loading control. The right panel shows the changes in p16 INK4A expression compared to passage 2 (p2) of B6-STIL control MEFs. ( F ) RNA sequencing showing p16 INK4A mRNA levels in CMV-STIL +/- and CMV-STIL +/+ relative to B6-STIL control MEFs. ( G , H) Percentage of ( G ) Apo-15-positive and ( H ) sub-G 1 phase, apoptotic B6-STIL control, CMV-STIL +/- , CMV-STIL +/+ , CMV-p53-R172H +/- and CMV-STIL +/- /p53-R172H +/- MEFs. Data are means ± SEM from three independent experiments. The differences between groups were tested using the one-way ANOVA with post-hoc Tukey test for multiple comparison. No statistical significance was found. For space reasons, only statistically significant differences are displayed. ( I ) Genotyping of p3-5 CMV-STIL +/- and CMV-STIL +/+ MEFs. All passages harbor the STIL transgene. ( J ) RNA sequencing showing STIL mRNA levels in p3-5 B6-STIL control, CMV-STIL +/- and CMV-STIL +/+ MEFs. ( K ) Immunoblotting showing STIL protein expression levels in p1-5 of B6-STIL control and CMV-STIL +/- MEFs. The STIL band at 170 kDa is marked with an asterisk. β-actin served as a loading control. The lower panel shows the changes in STIL expression compared to p1 of CMV-STIL +/- MEFs. ( L ) Percentage of p3 and p6 B6-STIL control, CMV-STIL +/- , CMV-STIL +/+ , CMV-p53-R172H +/- and CMV-STIL +/- /p53-R172H +/- MEFs with supernumerary centrioles. Comparisons were made using the two-sided Fisher’s exact test. Note : for reasons of space, only statistically significant differences were marked. * p <0.05, ** p <0.01, *** p <0.001.

    Techniques Used: Control, Western Blot, Expressing, Phospho-proteomics, Staining, RNA Sequencing, Comparison



    Similar Products

    95
    Cell Signaling Technology Inc mock controls wildtype mefs
    ( A ) Proliferation of B6-STIL control, CMV-STIL +/- , CMV-STIL +/+ , CMV-p53-R172H +/- and CMV-STIL +/- /p53-R172H +/- <t>MEFs.</t> Cells were enumerated every 24 h for a total of 5 days. Data are means ± SEM from three independent experiments. ( B ) Immunoblotting showing p S18 -p53 and p53 protein expression levels in protein extracts from p2-6 CMV-STIL +/- and B6-STIL control MEFs. β-actin served as a loading <t>control;</t> <t>DMSO-</t> and etoposide-treated NIH3T3 cell lysate extracts as controls for p53 increase/phosphorylation after DNA damage. The right panel shows the changes in p S18 -p53 and p53 expression compared to passage 2 (p2) of B6-STIL control MEFs. ( C ) Representative images of B6-STIL control, CMV-STIL +/- and CMV-STIL +/+ MEFs, stained for β-galactosidase-cleaved x-Gal (lower panel). In the upper panel differential contrast interference (DIC) images of the cells are shown. Scale bar, 1 μm. ( D ) Percentage of β-galactosidase-positive, senescent B6-STIL control, CMV-STIL +/- , CMV-STIL +/+ , CMV-p53-R172H +/- and CMV-STIL +/- /p53-R172H +/- MEFs. Data are means ± Clopper-Pearson 95%-CI. Comparisons were made using the two-sided Fisher’s exact test. For space reasons, only statistically significant differences are displayed. * p <0.05, ** p <0.01, *** p <0.001. ( E ) Immunoblotting showing p16 INK4A protein expression levels in protein extracts from p2-6 CMV-STIL +/- and B6-STIL control MEFs. β-actin served as a loading control. The right panel shows the changes in p16 INK4A expression compared to passage 2 (p2) of B6-STIL control MEFs. ( F ) RNA sequencing showing p16 INK4A mRNA levels in CMV-STIL +/- and CMV-STIL +/+ relative to B6-STIL control MEFs. ( G , H) Percentage of ( G ) Apo-15-positive and ( H ) sub-G 1 phase, apoptotic B6-STIL control, CMV-STIL +/- , CMV-STIL +/+ , CMV-p53-R172H +/- and CMV-STIL +/- /p53-R172H +/- MEFs. Data are means ± SEM from three independent experiments. The differences between groups were tested using the one-way ANOVA with post-hoc Tukey test for multiple comparison. No statistical significance was found. For space reasons, only statistically significant differences are displayed. ( I ) Genotyping of p3-5 CMV-STIL +/- and CMV-STIL +/+ MEFs. All passages harbor the STIL transgene. ( J ) RNA sequencing showing STIL mRNA levels in p3-5 B6-STIL control, CMV-STIL +/- and CMV-STIL +/+ MEFs. ( K ) Immunoblotting showing STIL protein expression levels in p1-5 of B6-STIL control and CMV-STIL +/- MEFs. The STIL band at 170 kDa is marked with an asterisk. β-actin served as a loading control. The lower panel shows the changes in STIL expression compared to p1 of CMV-STIL +/- MEFs. ( L ) Percentage of p3 and p6 B6-STIL control, CMV-STIL +/- , CMV-STIL +/+ , CMV-p53-R172H +/- and CMV-STIL +/- /p53-R172H +/- MEFs with supernumerary centrioles. Comparisons were made using the two-sided Fisher’s exact test. Note : for reasons of space, only statistically significant differences were marked. * p <0.05, ** p <0.01, *** p <0.001.
    Mock Controls Wildtype Mefs, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mock controls wildtype mefs/product/Cell Signaling Technology Inc
    Average 95 stars, based on 1 article reviews
    mock controls wildtype mefs - by Bioz Stars, 2026-02
    95/100 stars
      Buy from Supplier

    Image Search Results


    ( A ) Proliferation of B6-STIL control, CMV-STIL +/- , CMV-STIL +/+ , CMV-p53-R172H +/- and CMV-STIL +/- /p53-R172H +/- MEFs. Cells were enumerated every 24 h for a total of 5 days. Data are means ± SEM from three independent experiments. ( B ) Immunoblotting showing p S18 -p53 and p53 protein expression levels in protein extracts from p2-6 CMV-STIL +/- and B6-STIL control MEFs. β-actin served as a loading control; DMSO- and etoposide-treated NIH3T3 cell lysate extracts as controls for p53 increase/phosphorylation after DNA damage. The right panel shows the changes in p S18 -p53 and p53 expression compared to passage 2 (p2) of B6-STIL control MEFs. ( C ) Representative images of B6-STIL control, CMV-STIL +/- and CMV-STIL +/+ MEFs, stained for β-galactosidase-cleaved x-Gal (lower panel). In the upper panel differential contrast interference (DIC) images of the cells are shown. Scale bar, 1 μm. ( D ) Percentage of β-galactosidase-positive, senescent B6-STIL control, CMV-STIL +/- , CMV-STIL +/+ , CMV-p53-R172H +/- and CMV-STIL +/- /p53-R172H +/- MEFs. Data are means ± Clopper-Pearson 95%-CI. Comparisons were made using the two-sided Fisher’s exact test. For space reasons, only statistically significant differences are displayed. * p <0.05, ** p <0.01, *** p <0.001. ( E ) Immunoblotting showing p16 INK4A protein expression levels in protein extracts from p2-6 CMV-STIL +/- and B6-STIL control MEFs. β-actin served as a loading control. The right panel shows the changes in p16 INK4A expression compared to passage 2 (p2) of B6-STIL control MEFs. ( F ) RNA sequencing showing p16 INK4A mRNA levels in CMV-STIL +/- and CMV-STIL +/+ relative to B6-STIL control MEFs. ( G , H) Percentage of ( G ) Apo-15-positive and ( H ) sub-G 1 phase, apoptotic B6-STIL control, CMV-STIL +/- , CMV-STIL +/+ , CMV-p53-R172H +/- and CMV-STIL +/- /p53-R172H +/- MEFs. Data are means ± SEM from three independent experiments. The differences between groups were tested using the one-way ANOVA with post-hoc Tukey test for multiple comparison. No statistical significance was found. For space reasons, only statistically significant differences are displayed. ( I ) Genotyping of p3-5 CMV-STIL +/- and CMV-STIL +/+ MEFs. All passages harbor the STIL transgene. ( J ) RNA sequencing showing STIL mRNA levels in p3-5 B6-STIL control, CMV-STIL +/- and CMV-STIL +/+ MEFs. ( K ) Immunoblotting showing STIL protein expression levels in p1-5 of B6-STIL control and CMV-STIL +/- MEFs. The STIL band at 170 kDa is marked with an asterisk. β-actin served as a loading control. The lower panel shows the changes in STIL expression compared to p1 of CMV-STIL +/- MEFs. ( L ) Percentage of p3 and p6 B6-STIL control, CMV-STIL +/- , CMV-STIL +/+ , CMV-p53-R172H +/- and CMV-STIL +/- /p53-R172H +/- MEFs with supernumerary centrioles. Comparisons were made using the two-sided Fisher’s exact test. Note : for reasons of space, only statistically significant differences were marked. * p <0.05, ** p <0.01, *** p <0.001.

    Journal: PLOS Genetics

    Article Title: STIL overexpression shortens lifespan and reduces tumor formation in mice

    doi: 10.1371/journal.pgen.1011460

    Figure Lengend Snippet: ( A ) Proliferation of B6-STIL control, CMV-STIL +/- , CMV-STIL +/+ , CMV-p53-R172H +/- and CMV-STIL +/- /p53-R172H +/- MEFs. Cells were enumerated every 24 h for a total of 5 days. Data are means ± SEM from three independent experiments. ( B ) Immunoblotting showing p S18 -p53 and p53 protein expression levels in protein extracts from p2-6 CMV-STIL +/- and B6-STIL control MEFs. β-actin served as a loading control; DMSO- and etoposide-treated NIH3T3 cell lysate extracts as controls for p53 increase/phosphorylation after DNA damage. The right panel shows the changes in p S18 -p53 and p53 expression compared to passage 2 (p2) of B6-STIL control MEFs. ( C ) Representative images of B6-STIL control, CMV-STIL +/- and CMV-STIL +/+ MEFs, stained for β-galactosidase-cleaved x-Gal (lower panel). In the upper panel differential contrast interference (DIC) images of the cells are shown. Scale bar, 1 μm. ( D ) Percentage of β-galactosidase-positive, senescent B6-STIL control, CMV-STIL +/- , CMV-STIL +/+ , CMV-p53-R172H +/- and CMV-STIL +/- /p53-R172H +/- MEFs. Data are means ± Clopper-Pearson 95%-CI. Comparisons were made using the two-sided Fisher’s exact test. For space reasons, only statistically significant differences are displayed. * p <0.05, ** p <0.01, *** p <0.001. ( E ) Immunoblotting showing p16 INK4A protein expression levels in protein extracts from p2-6 CMV-STIL +/- and B6-STIL control MEFs. β-actin served as a loading control. The right panel shows the changes in p16 INK4A expression compared to passage 2 (p2) of B6-STIL control MEFs. ( F ) RNA sequencing showing p16 INK4A mRNA levels in CMV-STIL +/- and CMV-STIL +/+ relative to B6-STIL control MEFs. ( G , H) Percentage of ( G ) Apo-15-positive and ( H ) sub-G 1 phase, apoptotic B6-STIL control, CMV-STIL +/- , CMV-STIL +/+ , CMV-p53-R172H +/- and CMV-STIL +/- /p53-R172H +/- MEFs. Data are means ± SEM from three independent experiments. The differences between groups were tested using the one-way ANOVA with post-hoc Tukey test for multiple comparison. No statistical significance was found. For space reasons, only statistically significant differences are displayed. ( I ) Genotyping of p3-5 CMV-STIL +/- and CMV-STIL +/+ MEFs. All passages harbor the STIL transgene. ( J ) RNA sequencing showing STIL mRNA levels in p3-5 B6-STIL control, CMV-STIL +/- and CMV-STIL +/+ MEFs. ( K ) Immunoblotting showing STIL protein expression levels in p1-5 of B6-STIL control and CMV-STIL +/- MEFs. The STIL band at 170 kDa is marked with an asterisk. β-actin served as a loading control. The lower panel shows the changes in STIL expression compared to p1 of CMV-STIL +/- MEFs. ( L ) Percentage of p3 and p6 B6-STIL control, CMV-STIL +/- , CMV-STIL +/+ , CMV-p53-R172H +/- and CMV-STIL +/- /p53-R172H +/- MEFs with supernumerary centrioles. Comparisons were made using the two-sided Fisher’s exact test. Note : for reasons of space, only statistically significant differences were marked. * p <0.05, ** p <0.01, *** p <0.001.

    Article Snippet: As positive and mock controls wildtype MEFs were treated with 100 nM paclitaxel and DMSO, respectively for 48 h. Thereafter, MEFs were stained using the Senescence β-Galactosidase Staining Kit (Cell Signaling) according to manufacturer’s instructions and eosin as cytoplasmic counter staining to detect senescent cells.

    Techniques: Control, Western Blot, Expressing, Phospho-proteomics, Staining, RNA Sequencing, Comparison